Skip to content
Unrated Drug recall · FDA · Published August 24, 2019

Entropic Labs RAD-140 Capsules Recall: Unapproved SARMs Risk

Entropic Labs recalls 20mg RAD-140 capsules due to being marketed without FDA approval. This unapproved SARM product may pose health risks. Consumers should check their bottles for the UPC 651074545302.

🇺🇸 FDA recall #D-0800-2020DrugEntropic Labs ›
Take action

Contact the company

Recalling firmTuscano and Delucia Group (DBA Entropic Labs)2150 S West Temple Apt 413 · Salt Lake City, UT 84115
✎ GovInfoNow plain-language explainer

Entropic Labs is recalling all 20mg RAD-140 capsules because they were sold without FDA approval. Using unapproved SARMs could lead to health risks that aren't monitored by regulators. Read more at govinfonow.com/recall/38071-entropic-labs-rad-140-capsules-recall-unapproved-sarms-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/38071-entropic-labs-rad-140-capsules-recall-unapproved-sarms-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0800-2020

Cite this page

“Entropic Labs RAD-140 Capsules Recall: Unapproved SARMs Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38071-entropic-labs-rad-140-capsules-recall-unapproved-sarms-risk. Based on FDA recall #D-0800-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0800-2020%22&limit=1).

The Food and Drug Administration announced on August 24, 2019, that Tuscano and Delucia Group (DBA Entropic Labs) is recalling Entropic Labs SARM RAD-140 capsules. The agency stated the product was marketed without an approved New Drug Application or Abbreviated New Drug Application.

How to tell if you have it

  • Entropic Labs SARM RAD-140, 20mg Capsules, 30-count bottles
  • UPC: 651074545302

The hazard

The FDA classified the recall because the product contains Selective Androgen Receptor Modulators (SARMs) and was marketed without an approved NDA/ANDA.

Context

GovInfoNow's records show other recent recalls of similar products include StuffbyNainax MR 7 SUPER 700000 Capsules (2025-12-15), Asclemed Duloxetine Capsules Recall (2026-05-14), and Thea Pharma Similasan Eye Drops Recall (2026-04-23).

How to tell if you have this one

Check for the UPC number 651074545302 on the product label. The product is all 30-count bottles of 20mg RAD-140 capsules from Entropic Labs.

  • Brand
    Entropic Labs
  • Product
    Entropic Labs SARM RAD-140, 20mg Capsules, 30-count bottles, Entropic Labs UPC#: 651074545302
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the UPC number 651074545302 on the bottle to confirm it's the recalled product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 3.9 years after the firm started it.

1. Firm started the recall: Aug 24, 201912. FDA classified it Class II: Jan 22, 202023. Published in FDA’s Enforcement Report: Jan 29, 202034. FDA terminated the recall: Jul 12, 2023420192023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0800-2020 (August 24, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0800-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA